{"id":755565,"date":"2023-05-05T08:15:28","date_gmt":"2023-05-05T12:15:28","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/impel-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-friday-may-12-2023\/"},"modified":"2023-05-05T08:15:28","modified_gmt":"2023-05-05T12:15:28","slug":"impel-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-friday-may-12-2023","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/impel-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-friday-may-12-2023\/","title":{"rendered":"Impel Pharmaceuticals to Report First Quarter 2023 Financial Results on Friday, May 12, 2023"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">SEATTLE, May  05, 2023  (GLOBE NEWSWIRE) &#8212; Impel Pharmaceuticals Inc. (NASDAQ: IMPL), a commercial-stage pharmaceutical company developing transformative therapies for people suffering from diseases with high unmet medical needs, today announced it will host a live webcast on Friday, May 12, 2023, at 8:30 a.m. ET to report its first quarter 2023 financial results and provide a business update.<\/p>\n<p align=\"justify\">To access the live conference call, please register using the conference link: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=KLNePXEZrH3ojTqDlrvougJFOWVRkRSuXQ39nBbnU2COunDpRhAelh_8_gf9NgdtPoBOOZCqiVgeadw3y4dHKAISxq5O07g3DgSpIUGfVuO6iFV0WhSNYLExteZQ_WnbN9Hvm9m3xJPHK7grYSkHPDjYJgwL4998tr3EFXyLXUYLduQqx31EOmToqm4pRTIK\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/register.vevent.com\/register<\/a>. A live webcast of the event will be available on the Investors section of the Impel Pharmaceuticals website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=KLNePXEZrH3ojTqDlrvouvOTez-HtAnE_IcXWfDmHRSjtLFHRkDiOoaivieWjGYHndcpI1NeypGQUTK8AqZC_OzmYYAZvZ2fsaPhJp3Yg-5t8IDJbc_xqcvjo6lN7SFH\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/investors.impelpharma.com\/<\/a>. A replay of the webcast and accompanying slides will be available on the Impel Pharmaceuticals website following the event.<\/p>\n<p align=\"justify\">\n        <strong>About Impel Pharmaceuticals <\/strong><br \/>\n        <br \/>Impel Pharmaceuticals is a commercial-stage pharmaceutical company developing transformative therapies for people suffering from diseases with high unmet medical needs. Impel offers treatments that pair its proprietary POD<sup>\u00ae<\/sup>\u00a0technology with well-established therapeutics. In September 2021, Impel received U.S. FDA approval for its first product, Trudhesa\u00ae nasal spray, which is approved in the U.S. for the acute treatment of migraine with or without aura in adults. In addition to Trudhesa, the Company continues to address patient needs via licensing and partnerships.<\/p>\n<p align=\"justify\">For additional information about Impel, please visit www.ImpelPharma.com<\/p>\n<p align=\"justify\">\n        <strong>Contact:<\/strong>\n      <\/p>\n<p align=\"justify\">\n        <strong>Media Relations<\/strong>:<br \/>Melyssa Weible<br \/>Elixir Health Public Relations<br \/>Phone: (1) 386-366-0616<br \/>Email:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8Dbf4SVR2BeOpu8Sk7JvrmClzRzovo7NyJOAcen7F-xcOGTJnMjkC4CQDL8Q_6G89Ra0y1LcfJ7vc53o_dZj5Glo9-Hj1JlSqMkFvIVBgAuArKSsvt1g_urdFF-YZOCW\" rel=\"nofollow noopener\" target=\"_blank\">mweible@elixirhealthpr.com<\/a>\u00a0<\/p>\n<p>\n        <strong>Investor Relations<\/strong><br \/>\n        <br \/>Janhavi Mohite<br \/>Stern Investor Relations<br \/>Phone: 212-362-1200<br \/>Email: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-zZscZ61XPjcjx6F5J95xte7ZogX1zxayoziKwvzxJBOxzIlW_JUpjJiK-I7PJ1h1J5NnGeZwQ6IPn-Qe75zrKKCj157nbf88lb-Hz2AKhR0XBRNEMpAu1qnE3fndXq4\" rel=\"nofollow noopener\" target=\"_blank\">janhavi.mohite@sternir.com<\/a>\u00a0<\/p>\n<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMjc0OCM1NTc3MTc3IzIxODczOTI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/ZTU5NWViN2YtNTNmZi00ZjM4LTg3NDktN2VmZjJmNThlYmMzLTExOTg5NDU=\/tiny\/Impel-Pharmaceuticals.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SEATTLE, May 05, 2023 (GLOBE NEWSWIRE) &#8212; Impel Pharmaceuticals Inc. (NASDAQ: IMPL), a commercial-stage pharmaceutical company developing transformative therapies for people suffering from diseases with high unmet medical needs, today announced it will host a live webcast on Friday, May 12, 2023, at 8:30 a.m. ET to report its first quarter 2023 financial results and provide a business update. To access the live conference call, please register using the conference link: https:\/\/register.vevent.com\/register. A live webcast of the event will be available on the Investors section of the Impel Pharmaceuticals website at https:\/\/investors.impelpharma.com\/. A replay of the webcast and accompanying slides will be available on the Impel Pharmaceuticals website following the event. About Impel Pharmaceuticals Impel Pharmaceuticals is a commercial-stage pharmaceutical &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/impel-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-friday-may-12-2023\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Impel Pharmaceuticals to Report First Quarter 2023 Financial Results on Friday, May 12, 2023&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-755565","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Impel Pharmaceuticals to Report First Quarter 2023 Financial Results on Friday, May 12, 2023 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/impel-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-friday-may-12-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Impel Pharmaceuticals to Report First Quarter 2023 Financial Results on Friday, May 12, 2023 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SEATTLE, May 05, 2023 (GLOBE NEWSWIRE) &#8212; Impel Pharmaceuticals Inc. (NASDAQ: IMPL), a commercial-stage pharmaceutical company developing transformative therapies for people suffering from diseases with high unmet medical needs, today announced it will host a live webcast on Friday, May 12, 2023, at 8:30 a.m. ET to report its first quarter 2023 financial results and provide a business update. To access the live conference call, please register using the conference link: https:\/\/register.vevent.com\/register. A live webcast of the event will be available on the Investors section of the Impel Pharmaceuticals website at https:\/\/investors.impelpharma.com\/. A replay of the webcast and accompanying slides will be available on the Impel Pharmaceuticals website following the event. About Impel Pharmaceuticals Impel Pharmaceuticals is a commercial-stage pharmaceutical &hellip; Continue reading &quot;Impel Pharmaceuticals to Report First Quarter 2023 Financial Results on Friday, May 12, 2023&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/impel-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-friday-may-12-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-05T12:15:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMjc0OCM1NTc3MTc3IzIxODczOTI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/impel-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-friday-may-12-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/impel-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-friday-may-12-2023\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Impel Pharmaceuticals to Report First Quarter 2023 Financial Results on Friday, May 12, 2023\",\"datePublished\":\"2023-05-05T12:15:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/impel-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-friday-may-12-2023\\\/\"},\"wordCount\":245,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/impel-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-friday-may-12-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMjc0OCM1NTc3MTc3IzIxODczOTI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/impel-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-friday-may-12-2023\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/impel-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-friday-may-12-2023\\\/\",\"name\":\"Impel Pharmaceuticals to Report First Quarter 2023 Financial Results on Friday, May 12, 2023 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/impel-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-friday-may-12-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/impel-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-friday-may-12-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMjc0OCM1NTc3MTc3IzIxODczOTI=\",\"datePublished\":\"2023-05-05T12:15:28+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/impel-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-friday-may-12-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/impel-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-friday-may-12-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/impel-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-friday-may-12-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMjc0OCM1NTc3MTc3IzIxODczOTI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMjc0OCM1NTc3MTc3IzIxODczOTI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/impel-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-friday-may-12-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Impel Pharmaceuticals to Report First Quarter 2023 Financial Results on Friday, May 12, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Impel Pharmaceuticals to Report First Quarter 2023 Financial Results on Friday, May 12, 2023 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/impel-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-friday-may-12-2023\/","og_locale":"en_US","og_type":"article","og_title":"Impel Pharmaceuticals to Report First Quarter 2023 Financial Results on Friday, May 12, 2023 - Market Newsdesk","og_description":"SEATTLE, May 05, 2023 (GLOBE NEWSWIRE) &#8212; Impel Pharmaceuticals Inc. (NASDAQ: IMPL), a commercial-stage pharmaceutical company developing transformative therapies for people suffering from diseases with high unmet medical needs, today announced it will host a live webcast on Friday, May 12, 2023, at 8:30 a.m. ET to report its first quarter 2023 financial results and provide a business update. To access the live conference call, please register using the conference link: https:\/\/register.vevent.com\/register. A live webcast of the event will be available on the Investors section of the Impel Pharmaceuticals website at https:\/\/investors.impelpharma.com\/. A replay of the webcast and accompanying slides will be available on the Impel Pharmaceuticals website following the event. About Impel Pharmaceuticals Impel Pharmaceuticals is a commercial-stage pharmaceutical &hellip; Continue reading \"Impel Pharmaceuticals to Report First Quarter 2023 Financial Results on Friday, May 12, 2023\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/impel-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-friday-may-12-2023\/","og_site_name":"Market Newsdesk","article_published_time":"2023-05-05T12:15:28+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMjc0OCM1NTc3MTc3IzIxODczOTI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/impel-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-friday-may-12-2023\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/impel-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-friday-may-12-2023\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Impel Pharmaceuticals to Report First Quarter 2023 Financial Results on Friday, May 12, 2023","datePublished":"2023-05-05T12:15:28+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/impel-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-friday-may-12-2023\/"},"wordCount":245,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/impel-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-friday-may-12-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMjc0OCM1NTc3MTc3IzIxODczOTI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/impel-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-friday-may-12-2023\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/impel-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-friday-may-12-2023\/","name":"Impel Pharmaceuticals to Report First Quarter 2023 Financial Results on Friday, May 12, 2023 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/impel-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-friday-may-12-2023\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/impel-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-friday-may-12-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMjc0OCM1NTc3MTc3IzIxODczOTI=","datePublished":"2023-05-05T12:15:28+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/impel-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-friday-may-12-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/impel-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-friday-may-12-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/impel-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-friday-may-12-2023\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMjc0OCM1NTc3MTc3IzIxODczOTI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMjc0OCM1NTc3MTc3IzIxODczOTI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/impel-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-friday-may-12-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Impel Pharmaceuticals to Report First Quarter 2023 Financial Results on Friday, May 12, 2023"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/755565","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=755565"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/755565\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=755565"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=755565"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=755565"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}